Sale!

SPRED1 Gene Neurofibromatosis Type 1 -Like Syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “SPRED1 Gene Neurofibromatosis Type 1-Like Syndrome Genetic Test” is a specialized diagnostic examination conducted to identify mutations in the SPRED1 gene, which are known to cause Legius syndrome, a condition closely resembling Neurofibromatosis Type 1 (NF1). Legius syndrome, also known as Neurofibromatosis Type 1-like syndrome, shares many clinical features with NF1, including café-au-lait spots and freckling, but lacks the neurofibromas that are characteristic of NF1. The test is crucial for distinguishing between these two conditions, allowing for accurate diagnosis and appropriate management.

This genetic test involves analyzing the patient’s DNA to detect any mutations in the SPRED1 gene that are indicative of Legius syndrome. Early diagnosis through this genetic testing is essential for the implementation of suitable monitoring and intervention strategies, potentially improving the patient’s quality of life and reducing the risk of complications associated with misdiagnosis.

The test is available at DNA Labs UAE, a reputable facility known for its comprehensive genetic testing services. The cost of the SPRED1 Gene Neurofibromatosis Type 1-Like Syndrome Genetic Test is 4400 AED. Given the complexity and the specialized nature of this genetic test, the price reflects the intricate processes involved in ensuring accurate and reliable results. Individuals who exhibit symptoms suggestive of NF1 or Legius syndrome or have a family history of these conditions may consider undergoing this test after consulting with a healthcare professional to confirm the diagnosis and receive personalized medical advice.

Description

SPRED1 Gene Neurofibromatosis type 1-like syndrome Genetic Test

Test Name: SPRED1 Gene Neurofibromatosis type 1-like syndrome Genetic Test

Components: DNA Labs UAE offers the SPRED1 Gene Neurofibromatosis type 1-like syndrome Genetic Test at a price of 4400.0 AED.

Sample Condition: The test can be conducted using blood, extracted DNA, or one drop of blood on an FTA Card.

Report Delivery: The test results are typically delivered within 3 to 4 weeks.

Method: The SPRED1 Gene Neurofibromatosis type 1-like syndrome Genetic Test utilizes NGS (Next-Generation Sequencing) technology.

Test Type: This test is specifically designed for Osteology, Dermatology, and Immunology Disorders.

Doctor: The test is recommended to be conducted by a Dermatologist.

Test Department: The test is conducted by the Genetics department at DNA Labs UAE.

Pre Test Information: Prior to conducting the SPRED1 Gene Neurofibromatosis type 1-like syndrome Genetic Test, it is important to gather the clinical history of the patient. Additionally, a Genetic Counselling session is conducted to draw a pedigree chart of family members affected by SPRED1 Gene Neurofibromatosis type 1-like syndrome.

Test Details: The SPRED1 gene is associated with a genetic condition known as Neurofibromatosis type 1-like syndrome. This syndrome is characterized by the development of multiple tumors on the nerves, skin, and other parts of the body. While individuals with NF1-like syndrome exhibit similar symptoms to NF1, they do not have mutations in the NF1 gene. The NGS genetic testing method allows for the analysis of multiple genes simultaneously. In the context of SPRED1 gene and NF1-like syndrome, this test can identify mutations or variations in the SPRED1 gene that may be responsible for the condition. The test involves obtaining a DNA sample, usually through a blood or saliva sample, and sequencing it using NGS technology to identify any variations or mutations in the SPRED1 gene. The results of the test can confirm a diagnosis of NF1-like syndrome and provide information about the specific genetic changes involved.

Benefits of Genetic Testing: Genetic testing for SPRED1 gene and NF1-like syndrome can provide a definitive diagnosis, guide treatment decisions, and offer information about the risk of passing the condition on to future generations. It is crucial to have the test performed and interpreted by a qualified healthcare professional or genetic counselor who can provide appropriate counseling and support. They can explain the benefits, limitations, and potential implications of the test results.

Test Name	SPRED1 Gene Neurofibromatosis type 1 -like syndrome Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for SPRED1 Gene Neurofibromatosis type 1 -like syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SPRED1 Gene Neurofibromatosis type 1 -like syndrome NGS Genetic DNA Test gene SPRED1
Test Details	The SPRED1 gene is associated with a genetic condition called Neurofibromatosis type 1-like syndrome. Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by the development of multiple tumors on the nerves, skin, and other parts of the body. NF1-like syndrome refers to individuals who have similar symptoms to NF1 but do not have mutations in the NF1 gene. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of SPRED1 gene and NF1-like syndrome, NGS genetic testing can be used to identify mutations or variations in the SPRED1 gene that may be responsible for the condition. The NGS genetic test for SPRED1 gene and NF1-like syndrome involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any variations or mutations in the SPRED1 gene. The results of the test can help confirm a diagnosis of NF1-like syndrome and provide information about the specific genetic changes involved. Genetic testing for SPRED1 gene and NF1-like syndrome can be beneficial for individuals who have symptoms similar to NF1 but do not have mutations in the NF1 gene. It can help provide a definitive diagnosis, guide treatment decisions, and provide information about the risk of passing the condition on to future generations. It is important to note that genetic testing should be performed and interpreted by a qualified healthcare professional or genetic counselor who can provide appropriate counseling and support. They can explain the benefits, limitations, and potential implications of the test results.